2019 Annual Meeting | C203 - Comprehensive Migraine Update II: Pharmacologic and Non-Pharmacologic Therapies

Date Wednesday 05/08/19

Time 03:30 PM - 05:30 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Gretchen E. Tietjen, MD

Topic(s) Headache

Learning Objectives Participants should be able to describe acute migraine and recognize risk factors for and treatment of medication overuse headache; discuss preventive strategies, including medications (per evidence-based guidelines), neurostimulation, and procedural treatments; and describe cognitive behavioral therapy and locate resources for patients without access to psychologists.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:40 PM EDT	Introduction	Introduction Gretchen E. Tietjen, MD
03:40 PM - 04:10 PM EDT	Speaker	Advances in Acute Migraine Treatment Gretchen E. Tietjen, MD
04:10 PM - 04:40 PM EDT	Speaker	Advances in Preventive Strategies Bert B. Vargas, MD, FAAN
04:40 PM - 05:10 PM EDT	Speaker	Behavioral Therapies for Migraine Elizabeth Seng, PhD, Frank Andrasik
05:10 PM - 05:30 PM EDT	Discussion	Panel Discussion/Questions and Answers
05:30 PM - 06:00 PM EDT	Discussion	Continuing the Conversation

Faculty Disclosures
Gretchen E. Tietjen, MD	Dr. Tietjen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Tietjen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CME Outfitters. An immediate family member of Dr. Tietjen has stock in Johnson & Johnson.
Bert B. Vargas, MD, FAAN	Dr. Vargas has received personal compensation for serving as an employee of Lilly USA. Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Football League. Dr. Vargas has stock in Eli Lilly. An immediate family member of Dr. Vargas has stock in Pfizer. Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Unaffiliated Neurotrauma Consultant with National Football League. Dr. Vargas has received personal compensation in the range of $10,000-$49,999 for serving as a Neurotrauma Consultant with National Association for Stock Car Auto Racing.
Elizabeth Seng, PhD	Dr. Seng has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Seng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. The institution of Dr. Seng has received research support from NINDS.
Frank Andrasik	No disclosure on file